iZafe Group (IZAFE-B) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
28 Apr, 2026Executive summary
Net sales for Q1 2026 reached 2,419 TSEK, up from 1,318 TSEK year-over-year, driven entirely by recurring license revenues; no hardware sales occurred during the period.
Operational focus was on building a strong sales pipeline, especially in Sweden via the ADDA framework agreement, and strengthening the Dutch organization.
Significant contracts were secured, including the ADDA national procurement and Region Jönköping, with further agreements signed after the quarter.
A directed share issue of approximately SEK 19.8 million was completed to accelerate sales and installations.
New product launches included a modular external display for Dosell and a remote care system, with gradual introduction planned for 2026.
Financial highlights
Net sales increased 83.5% year-over-year to 2,419 TSEK, with recurring license revenues as the sole contributor.
Operating result (EBIT) was -8,300 TSEK, down from -5,243 TSEK year-over-year, reflecting higher depreciation and consolidation of Dutch operations.
EBITDA was -4,311 TSEK, compared to -2,538 TSEK in Q1 2025.
Net result for the period was -6,475 TSEK, impacted by currency fluctuations and increased amortization from acquisitions.
Cash flow from operating activities improved to -4,653 TSEK from -7,013 TSEK year-over-year.
Earnings per share before/after dilution was -0.02 SEK, unchanged year-over-year.
Outlook and guidance
Full-year ARR forecast remains unchanged, with potential upside linked to the ADDA framework agreement.
Strong sales pipeline and new contracts are expected to drive accelerated growth and recurring revenue in coming quarters.
Investments in sales, implementation, and support are expected to convert pipeline into revenue.
Latest events from iZafe Group
- Recurring revenue model established; Nordic expansion and Dutch acquisition drive growth.IZAFE-B
Q4 202523 Apr 2026 - Recurring revenue model established, ARR at 10 MSEK, and Nordic expansion underway.IZAFE-B
Q3 202523 Apr 2026 - Recurring revenue model established, ARR quadrupled, and European expansion accelerates.IZAFE-B
Q3 20253 Nov 2025 - Recurring revenue growth and European expansion drive strong momentum in Q2 2025.IZAFE-B
Q2 202529 Aug 2025 - Revenue surged as Dosell expanded, with losses narrowing and growth momentum accelerating.IZAFE-B
Q3 202413 Jun 2025 - Net sales fell in Q2, but demand and new contracts signal growth ahead.IZAFE-B
Q2 202413 Jun 2025 - Recurring revenues and international expansion drive improved results and future growth.IZAFE-B
Q1 20256 Jun 2025 - Revenue doubled and ARR surged as iZafe accelerates international expansion.IZAFE-B
Q4 20245 Jun 2025